Taiwan · Delayed Price · Currency is TWD TTY Biopharm Company Statistics
Total Valuation
TPEX:4105 has a market cap or net worth of TWD 18.50 billion. The enterprise value is 18.02 billion.
| Market Cap | 18.50B |
| Enterprise Value | 18.02B |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | Mar 26, 2026 |
Share Statistics
TPEX:4105 has 248.65 million shares outstanding. The number of shares has decreased by -0.04% in one year.
| Current Share Class | 248.65M |
| Shares Outstanding | 248.65M |
| Shares Change (YoY) | -0.04% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 10.36% |
| Owned by Institutions (%) | 9.25% |
| Float | 199.07M |
Valuation Ratios
The trailing PE ratio is 11.88 and the forward PE ratio is 10.88.
| PE Ratio | 11.88 |
| Forward PE | 10.88 |
| PS Ratio | 2.87 |
| PB Ratio | 2.30 |
| P/TBV Ratio | 2.72 |
| P/FCF Ratio | 11.10 |
| P/OCF Ratio | 10.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.72, with an EV/FCF ratio of 10.81.
| EV / Earnings | 11.56 |
| EV / Sales | 2.79 |
| EV / EBITDA | 8.72 |
| EV / EBIT | 9.64 |
| EV / FCF | 10.81 |
Financial Position
The company has a current ratio of 2.28, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.28 |
| Quick Ratio | 1.56 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.66 |
| Debt / FCF | 0.75 |
| Interest Coverage | 44.08 |
Financial Efficiency
Return on equity (ROE) is 21.27% and return on invested capital (ROIC) is 19.47%.
| Return on Equity (ROE) | 21.27% |
| Return on Assets (ROA) | 9.59% |
| Return on Invested Capital (ROIC) | 19.47% |
| Return on Capital Employed (ROCE) | 19.57% |
| Weighted Average Cost of Capital (WACC) | 4.37% |
| Revenue Per Employee | 18.87M |
| Profits Per Employee | 4.56M |
| Employee Count | 342 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.06 |
Taxes
In the past 12 months, TPEX:4105 has paid 470.47 million in taxes.
| Income Tax | 470.47M |
| Effective Tax Rate | 22.14% |
Stock Price Statistics
The stock price has decreased by -4.31% in the last 52 weeks. The beta is 0.05, so TPEX:4105's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | -4.31% |
| 50-Day Moving Average | 82.90 |
| 200-Day Moving Average | 79.51 |
| Relative Strength Index (RSI) | 20.99 |
| Average Volume (20 Days) | 1,077,108 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4105 had revenue of TWD 6.45 billion and earned 1.56 billion in profits. Earnings per share was 6.26.
| Revenue | 6.45B |
| Gross Profit | 3.72B |
| Operating Income | 1.70B |
| Pretax Income | 2.13B |
| Net Income | 1.56B |
| EBITDA | 1.90B |
| EBIT | 1.70B |
| Earnings Per Share (EPS) | 6.26 |
Balance Sheet
The company has 2.55 billion in cash and 1.26 billion in debt, with a net cash position of 1.30 billion or 5.21 per share.
| Cash & Cash Equivalents | 2.55B |
| Total Debt | 1.26B |
| Net Cash | 1.30B |
| Net Cash Per Share | 5.21 |
| Equity (Book Value) | 8.05B |
| Book Value Per Share | 29.10 |
| Working Capital | 3.37B |
Cash Flow
In the last 12 months, operating cash flow was 1.76 billion and capital expenditures -94.61 million, giving a free cash flow of 1.67 billion.
| Operating Cash Flow | 1.76B |
| Capital Expenditures | -94.61M |
| Depreciation & Amortization | 196.58M |
| Net Borrowing | -508.61M |
| Free Cash Flow | 1.67B |
| FCF Per Share | 6.71 |
Margins
Gross margin is 57.66%, with operating and profit margins of 26.41% and 24.16%.
| Gross Margin | 57.66% |
| Operating Margin | 26.41% |
| Pretax Margin | 32.93% |
| Profit Margin | 24.16% |
| EBITDA Margin | 29.45% |
| EBIT Margin | 26.41% |
| FCF Margin | 25.84% |
Dividends & Yields
This stock pays an annual dividend of 4.20, which amounts to a dividend yield of 5.25%.
| Dividend Per Share | 4.20 |
| Dividend Yield | 5.25% |
| Dividend Growth (YoY) | 7.14% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 66.98% |
| Buyback Yield | 0.04% |
| Shareholder Yield | 5.31% |
| Earnings Yield | 8.43% |
| FCF Yield | 9.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 13, 2014. It was a forward split with a ratio of 1.067.
| Last Split Date | Aug 13, 2014 |
| Split Type | Forward |
| Split Ratio | 1.067 |
Scores
TPEX:4105 has an Altman Z-Score of 5.47 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.47 |
| Piotroski F-Score | 6 |